Bauchi DMMA Targets N400m DRF In Year 2022.

By Murtala Muhammad

Bauchi State Drugs and Medical Consumables Management Agency (DMMA) is targeting about four hundred million naira in cash and stock this year under its Drug Revolving Fund, DRF scheme.

Similarly, the agency generated over one hundred million naira including initial capital in 2021.

The Managing Director of the Agency, Abdulkadir Ahmed stated this while interacting with journalists on the agency’s successes and challenges in the year 2021.

The Drug Revolving Fund (DRF) is a scheme established to make drugs and medical consumables available for both primary and secondary public health facilities in the state with the aim of making a profit so as not to run out of stock.

Abdulkadir Ahmed said the agency had secured approval and subsequent release of twenty-four million naira in January 2021 for the state DRF and was able to make a profit of about ninety six million naira in both cash and stock by the end of December.

He explained that the DMMA through funding from the state and partners had increased participation from one hundred and four to two hundred and thirty four primary health facilities under the DRF scheme.

Ahmed noted that tremendous progress has been recorded in the year under review to include successful launch of fully operational stores at Azare and Ningi for the northern and central zones which were constructed in 2017.

According to him, the two stores have eased access to drugs and other medical consumables for all the primary healthcare facilities in the two zones as against previous years where only the Central Store situated in the state capital serves the same purpose.

The DMMA is saddled with the responsibility of ensuring that health commodities are adequately made available to benefitting public health facilities in the state.